AR048137A1 - Forma de dosificacion oral farmaceutica que comprende un farmaco antiinflamatorio no esteroideo, y que tiene un sabor agradable. - Google Patents

Forma de dosificacion oral farmaceutica que comprende un farmaco antiinflamatorio no esteroideo, y que tiene un sabor agradable.

Info

Publication number
AR048137A1
AR048137A1 ARP040104719A ARP040104719A AR048137A1 AR 048137 A1 AR048137 A1 AR 048137A1 AR P040104719 A ARP040104719 A AR P040104719A AR P040104719 A ARP040104719 A AR P040104719A AR 048137 A1 AR048137 A1 AR 048137A1
Authority
AR
Argentina
Prior art keywords
dosage form
pharmaco
inflammatory
oral dosage
form including
Prior art date
Application number
ARP040104719A
Other languages
English (en)
Inventor
Francesca Mariotti
Lorella Ragni
Leonardo Marchitto
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of AR048137A1 publication Critical patent/AR048137A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Forma de dosificacion farmacéutica oral que comprende trometamina y un NSAID seleccionado de entre el grupo que comprende ibuprofeno, naproxeno y flurbiprofeno, caracterizada porque comprende también un compuesto seleccionado de entre el grupo que comprende glicina, vitamina B6 y mezclas de los mismos.
ARP040104719A 2003-12-19 2004-12-17 Forma de dosificacion oral farmaceutica que comprende un farmaco antiinflamatorio no esteroideo, y que tiene un sabor agradable. AR048137A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002523A ITMI20032523A1 (it) 2003-12-19 2003-12-19 Forma di dosaggio per uso orale comprendente un farmaco

Publications (1)

Publication Number Publication Date
AR048137A1 true AR048137A1 (es) 2006-04-05

Family

ID=34685625

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040104719A AR048137A1 (es) 2003-12-19 2004-12-17 Forma de dosificacion oral farmaceutica que comprende un farmaco antiinflamatorio no esteroideo, y que tiene un sabor agradable.

Country Status (21)

Country Link
US (1) US9968552B2 (es)
EP (1) EP1694295B1 (es)
JP (1) JP4958558B2 (es)
KR (1) KR101122174B1 (es)
CN (1) CN100486643C (es)
AR (1) AR048137A1 (es)
AU (1) AU2004298763B2 (es)
BR (1) BRPI0417809B1 (es)
CA (1) CA2547194C (es)
DK (1) DK1694295T3 (es)
EA (1) EA009515B1 (es)
ES (1) ES2388139T3 (es)
HK (1) HK1091404A1 (es)
IL (1) IL175827A0 (es)
IT (1) ITMI20032523A1 (es)
MX (1) MXPA06007052A (es)
PL (1) PL1694295T3 (es)
PT (1) PT1694295E (es)
SI (1) SI1694295T1 (es)
UA (1) UA83531C2 (es)
WO (1) WO2005058276A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
PL3236938T3 (pl) * 2014-12-25 2019-10-31 Sanovel Ilac Sanayi Ve Ticaret As Doustne miejscowe wodne kompozycje farmaceutyczne flurbiprofenu i dekspantenolu
US20180228832A1 (en) * 2015-08-18 2018-08-16 Pharma Seeds Create, Llc Stomatological composition containing nsaid or heparin compound
EP3406239B1 (en) * 2017-05-22 2021-10-20 Epifarma Srl Palatable ketoprofen lysine salt solutions
KR20200094161A (ko) 2017-11-30 2020-08-06 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이 케토프로펜, 이의 염 및 거울상 이성질체의 안정한 액체 조성물
MX2022002353A (es) * 2019-08-26 2022-04-06 Dsm Ip Assets Bv Forma de dosificacion oral solida que comprende naproxeno y vitamina b1.
KR20230090186A (ko) 2021-12-14 2023-06-21 메디케어제약 주식회사 파라세타몰 및 나프록센을 포함하는 약제학적 복합제제
CN114129512B (zh) * 2021-12-14 2023-12-22 艾迈华创(武汉)科技有限公司 一种可口服用萘普生溶液制剂及其制备方法与应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4028772A (en) 1971-04-02 1973-09-27 Merck & Co., Inc Chemical processes
HU185926B (en) 1979-09-27 1985-04-28 Agostne Kahan Process for preparing water soluble derivatives of non-steroid antiinflammatory compositions and pharmaceutical compositins containing such derivatives
JPH0768120B2 (ja) * 1987-03-09 1995-07-26 日清製粉株式会社 非ステロイド性抗炎症薬経口投与用組成物
US5296236A (en) * 1988-09-16 1994-03-22 Recordati S.A., Chemical And Pharmaceutical Company Controlled release therapeutic system for a liquid pharmaceutical formulations
US5183829A (en) * 1991-09-27 1993-02-02 Applied Analytical Industries, Inc. Oral liquid compositions of non-steroidal anti-inflammatory drugs
ZA945944B (en) * 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
US5626838A (en) * 1995-03-13 1997-05-06 The Procter & Gamble Company Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx
AU7637296A (en) * 1995-11-14 1997-06-05 Farmarc Nederland Bv Complex of naproxen and beta-cyclodextrin
GB9601398D0 (en) * 1996-01-24 1996-03-27 Piper Edwina M Composition
JPH11139970A (ja) * 1997-11-06 1999-05-25 Doujin Iyaku Kako Kk 経口液剤
US6426090B1 (en) * 1999-04-06 2002-07-30 Wm. Wrigley Jr. Company Over-coated product including tableted center and medicament
AR035642A1 (es) 2000-05-26 2004-06-23 Pharmacia Corp Uso de una composicion de celecoxib para el alivio rapido del dolor
PT1411899E (pt) * 2001-08-01 2009-04-24 Novartis Ag Composição de mascaramento de sabor
ITMI20020986A1 (it) * 2002-05-10 2003-11-10 Acraf Composizione a base di diclofenac per il trattamento topico di affezioni del cavo orofaringeo
EP1974751A1 (en) 2007-03-26 2008-10-01 The Jordanian Pharmaceutical Manufacturing Co. Formulations for non-steroidal anti-inflammatory drugs

Also Published As

Publication number Publication date
EA200601189A1 (ru) 2006-10-27
CN100486643C (zh) 2009-05-13
BRPI0417809A (pt) 2007-04-10
PL1694295T3 (pl) 2012-11-30
MXPA06007052A (es) 2007-01-30
KR101122174B1 (ko) 2012-03-15
SI1694295T1 (sl) 2012-10-30
ES2388139T3 (es) 2012-10-09
JP4958558B2 (ja) 2012-06-20
DK1694295T3 (da) 2012-09-24
AU2004298763A1 (en) 2005-06-30
KR20060120206A (ko) 2006-11-24
EA009515B1 (ru) 2008-02-28
HK1091404A1 (en) 2007-01-19
CA2547194C (en) 2011-12-13
UA83531C2 (uk) 2008-07-25
JP2007514701A (ja) 2007-06-07
WO2005058276A1 (en) 2005-06-30
EP1694295A1 (en) 2006-08-30
EP1694295B1 (en) 2012-06-20
AU2004298763B2 (en) 2009-12-03
US20080292606A1 (en) 2008-11-27
US9968552B2 (en) 2018-05-15
ITMI20032523A1 (it) 2005-06-20
CN1893922A (zh) 2007-01-10
BRPI0417809B1 (pt) 2018-09-25
IL175827A0 (en) 2006-10-05
CA2547194A1 (en) 2005-06-30
PT1694295E (pt) 2012-07-23

Similar Documents

Publication Publication Date Title
AR051397A1 (es) Composicion farmaceutica
IL166286A0 (en) Multicomponent pharmaceutical dosage form
CY1112640T1 (el) Μορφες δοσολογιας πολλαπλης στοιβαδας που περιεχουν ναπροξενη και τριπτανια
ATE328584T1 (de) In der mundhöhle schnell zerfallende orale feste verabreichungsform
ATE372765T1 (de) Feste pharmazeutische formulierungen mit telmisartan
DK1043977T3 (da) Oral farmaceutisk doseringsform baseret på pulserende frigørelse
ATE458486T1 (de) Feste, oral applizierbare pharmazeutische darreichungsformen enthaltend rivaroxaban mit modifizierter freisetzung
NO20053150D0 (no) System for administrasjon av medisin.
GT200800107A (es) Formulaciones orales que comprenden tigeciclina
HN2003000183A (es) Difenilazetidinonas sustituidas en anillo procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
DE602004006860D1 (de) Capsaicinoid enthaltende pharmazeutische zusammensetzung zur oralen verabreichung
CL2003002653A1 (es) Composicion farmaceutica que comprende (a) un antiinflamatorio no esteroidal (nsaid), preferentemente ibuprofeno, (b) un descongestionante, preferentemente pseudoefedrina y (c) un antihistaminico, preferentemente clorfeniramina; metodo para su prepar
DE60336225D1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
AR048137A1 (es) Forma de dosificacion oral farmaceutica que comprende un farmaco antiinflamatorio no esteroideo, y que tiene un sabor agradable.
NO20030231D0 (no) Proteinkompleks som fungerer som en vehikkel for oralt administrerbare medikamenter
CO5700723A2 (es) Uso de un derivado de amina ciclica especifico o de sus sales farmaceuticamente aceptables para tratar y prevenir la insuficiencia cardiaca
ATE327759T1 (de) Pharmazeutische zusammensetzung mit verlungerter freisetzung
ATE345776T1 (de) Osmotisches verabreichungssystem
DE60306747D1 (de) Perindopril enthaltende pharmazeutische zusammensetzung mit oraler dispersion
NO20043633L (no) Oral doseringsform for kontrollert medikamentfrigivning
DK1503803T3 (da) Injicerbar farmaceutisk sammensætning indeholdende ethanol til at behandle diskusprolaps
ITTO20020672A0 (it) Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale
NL1023797A1 (nl) Farmaceutische doseringsvorm die zwangerschapsvriendelijke onderscheidingstekens draagt.
ATE357220T1 (de) Pharmazeutische zusammensetzung mit modifizierter freisetzung
ITMI20030826A1 (it) Composizione farmaceutica contenente interferone per il

Legal Events

Date Code Title Description
FC Refusal